CervoMed Inc (CRVO)
24.09
-0.27
(-1.11%)
USD |
NASDAQ |
May 17, 16:00
23.91
-0.18
(-0.75%)
After-Hours: 20:00
CervoMed Cash from Operations (TTM): -7.392M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -7.392M |
| December 31, 2023 | -7.450M |
| September 30, 2023 | -5.604M |
| June 30, 2023 | -1.450M |
| March 31, 2023 | 0.6751M |
| December 31, 2022 | -2.573M |
| September 30, 2022 | -4.906M |
| June 30, 2022 | -14.74M |
| March 31, 2022 | -14.06M |
| December 31, 2021 | -14.50M |
| September 30, 2021 | -14.87M |
| June 30, 2021 | -15.41M |
| March 31, 2021 | -15.22M |
| December 31, 2020 | -13.55M |
| September 30, 2020 | -12.60M |
| June 30, 2020 | -11.24M |
| March 31, 2020 | -10.71M |
| December 31, 2019 | -9.858M |
| September 30, 2019 | -10.45M |
| June 30, 2019 | -10.21M |
| March 31, 2019 | -10.14M |
| December 31, 2018 | -10.77M |
| September 30, 2018 | -10.03M |
| June 30, 2018 | -12.00M |
| March 31, 2018 | -12.21M |
| Date | Value |
|---|---|
| December 31, 2017 | -12.33M |
| September 30, 2017 | -11.46M |
| June 30, 2017 | -9.441M |
| March 31, 2017 | -9.554M |
| December 31, 2016 | -10.77M |
| September 30, 2016 | -11.62M |
| June 30, 2016 | -10.74M |
| March 31, 2016 | -8.877M |
| December 31, 2015 | -5.185M |
| September 30, 2015 | -4.850M |
| June 30, 2015 | -5.847M |
| March 31, 2015 | -9.536M |
| December 31, 2014 | -9.030M |
| September 30, 2014 | -7.101M |
| June 30, 2014 | -5.455M |
| March 31, 2014 | -1.311M |
| December 31, 2013 | -1.185M |
| September 30, 2013 | -2.682M |
| June 30, 2013 | -2.908M |
| March 31, 2013 | -2.770M |
| December 31, 2012 | -4.310M |
| September 30, 2012 | -6.036M |
| June 30, 2012 | -9.929M |
| March 31, 2012 | -13.30M |
| December 31, 2011 | -12.02M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-15.41M
Minimum
Jun 2021
0.6751M
Maximum
Mar 2023
-9.805M
Average
-10.58M
Median
Cash from Operations (TTM) Benchmarks
| GlucoTrack Inc | -6.558M |
| AIM ImmunoTech Inc | -21.27M |
| Perspective Therapeutics Inc | -13.34M |
| Protalix BioTherapeutics Inc | 5.868M |
| Armata Pharmaceuticals Inc | -40.44M |